Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Clinical trials are a crucial part of the cancer research continuum, providing a testing ground for the safety and...
The cover of the inaugural issue of Blood Cancer Discovery, launched in July 2020, does not feature stained tissue...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Cancers that grow and disseminate to threaten life reside...
In recent months, Asians in America have been targets of increasing numbers of verbal insults and physical attacks. While...
For the month of June, the editors of the nine AACR journals highlighted results from two clinical trials, preclinical data on KRAS inhibitors...
Cancer researchers and cancer survivors are often viewed in separate silos. Scientists toil away alone in laboratories to decode the mechanisms of the disease and test novel molecules. Cancer...
Ten years ago, then-President of the AACR, Tyler Jacks, PhD, FAACR, conceived the idea for a “comprehensive, high-impact journal that would present new...
Most scientists, regardless of field or career stage, have faced difficulties networking and disseminating their research in the past year, with many conferences and symposia canceled. The...
In the ongoing quest to end cancer health disparities, there’s a simple tool that virtually anyone can use: honest...
The AACR Annual Meeting 2021 featured the theme “Discovery Science Driving Clinical Breakthroughs.” Indeed, over the course of two weeks,...